BioArctic AB (publ) announced today that it issued 20,200 Class B shares during August for delivery to participants in the 2019/2028 stock option program, following the exercise of 20,200 stock options of that series. As of August 31, 2026, the total number of shares in the company amounts to 88,744,685, comprising 74,344,689 listed Class B shares and 14,399,996 unlisted Class A shares. Each Class A share carries ten votes, while each Class B share carries one vote, bringing the total number of votes to 218,344,649. The disclosure was made pursuant to the Financial Instruments Trading Act and released on August 31, 2026, at 5:30 pm CEST.
BioArctic AB Series BIssuance of shares for option exercise, a routine capital event.
BioAge Labs, Inc